Skip to content
Tuesday, October 6, 2026
Fitness Exercise Pro

Fitness Exercise Pro

Unlocking Your Potential for a Healthier You

Tag: drug approval

  • Home
  • drug approval
  • pharma

Lupin USFDA Approval: A Smart Step for Apixaban Suspension

  • Mae Cooper
  • September 28, 2026
  • 0

Lupin USFDA approval is a significant milestone for Apixaban oral suspension, enhancing treatment options.

Drug Approval Times: What’s the Quickest Way to Get Them?
  • pharma

Drug Approval Times: What’s the Quickest Way to Get Them?

  • Mae Cooper
  • September 15, 2026
  • 0

Drug approval times are changing with the FDA’s new program. Discover how this impacts the pharmaceutical industry.

Contact us

Archives

  • October 2026
  • September 2026
  • June 2026
  • May 2026
  • March 2026
  • February 2026
  • November 2025
  • November 2024
  • January 2024
  • July 2023
  • May 2023
  • March 2023
  • November 2022

Categories

  • Beauty&Style
  • Business
  • Crypto
  • Dental
  • Diet
  • Fitness&Exercise
  • Food&Recipe
  • Health
  • International Relations
  • Medicalcare
  • pharma
  • Weightloss
  • Yoga

Pages

  • About Us
  • Contact Us
  • Write for Us
  • Advertise
  • Privacy Policy
  • Terms of Use

Tags

acquisition news anticoagulants Apixaban assistance Aurobindo Pharma Bayer Belgium Bilateral relations cancer drug clean energy defence drug approval everyday activities FDA approval fungal infections healthcare home care services homewatchcaregivers com novi India international cooperation investing investment news investors Israel Japan business Lupin Moberg Pharma nail fungus treatment Nordics oral suspension Perampanel personalized care pharmaceutical news pharmaceuticals pharma industry Roundup settlement senior home care stake cancellation stock market Technocraft Industries Technosoft Integrated Solutions Terclara trade USFDA USFDA approval

Calendar

October 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
« Sep    
Copyright © 2026 Fitness Exercise Pro Theme: Actual News By Adore Themes.